Comparison of minimum inhibitory concentration results for gepotidacin obtained using agar dilution and broth microdilution methods

SJR Arends, MA Canino, R Mendes… - … and Infectious Disease, 2020 - Elsevier
Gepotidacin (GSK2140944) is a first in class, novel triazaacenaphthylene bacterial type II
topoisomerase inhibitor in Phase 3 clinical development for the treatment of gonorrhea and …
被引用次数：12 相关文章

Comparison of minimum inhibitory concentration results for gepotidacin obtained using agar dilution and broth microdilution methods.

SJR Arends, MA Canino, R Mendes… - Diagnostic …, 2020 - europepmc.org
Gepotidacin (GSK2140944) is a first in class, novel triazaacenaphthylene bacterial type II
topoisomerase inhibitor in Phase 3 clinical development for the treatment of gonorrhea and …

[引用][C] Comparison of minimum inhibitory concentration results for gepotidacin obtained using agar dilution and broth microdilution methods

SJR Arends, MA Canino, R Mendes… - … and Infectious Disease, 2020 - cir.nii.ac.jp
Comparison of minimum inhibitory concentration results for gepotidacin obtained using agar
dilution and broth microdilution methods | CiNii Research CiNii 国立情報学研究所 学術情報 …

Comparison of minimum inhibitory concentration results for gepotidacin obtained using agar dilution and broth microdilution methods

SJR Arends, MA Canino, R Mendes… - Diagnostic …, 2020 - pubmed.ncbi.nlm.nih.gov
Gepotidacin (GSK2140944) is a first in class, novel triazaacenaphthylene bacterial type II
topoisomerase inhibitor in Phase 3 clinical development for the treatment of gonorrhea and …